학술논문

Phase III Trial of Adjuvant Sunitinib in Patients with High-Risk Renal Cell Carcinoma: Exploratory Pharmacogenomic Analysis
Document Type
Journal
Source
CLINICAL CANCER RESEARCH; FEB 15 2019, 25 4, p1165-p1173, 9p.
Subject
Language
English
ISSN
15573265